Sanofi
Paris Cedex· latest recorded location
Sanofi is named on 11 US grants and 4 published applications in this corpus. Its most frequent classification is A61P (Therapeutic uses of medicines).
- Granted patents
- 11
- Published applications
- 4
- Inventors
- 57
- Granted in 2026 so far
- 0
- Most recent grant
- 4 Jul 2023
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 1 | 0 |
| 1988 | 2 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 0 | 1 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 0 | 1 |
| 2020 | 0 | 0 |
| 2021 | 2 | 1 |
| 2022 | 0 | 0 |
| 2023 | 3 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Technology areas
Share of 15 documents
- A61PTherapeutic uses of medicines9
- C07KPeptides6
- A61KMedicines and medical preparations4
- A61MDevices for delivering substances into the body3
- C07CAcyclic or carbocyclic compounds3
- C07DHeterocyclic compounds3
- G01NInvestigating or analysing materials by determining their chemical or physical properties2
- G01FMeasuring volume, volume flow, mass flow or liquid level1
- Y02PLow-carbon manufacturing1
Recent patents
- Multifunctional natural killer (NK) cell engagers binding to NKp46 and CD1234 Jul 2023US 11,692,039 B2
- Plunger and drug delivery device21 Feb 2023US 11,583,634 B2
- Injector device14 Feb 2023US 11,577,032 B2
- Antibody formulations28 Dec 2021US 11,207,407 B2
- Pair of electrode pads4 May 2021US D918,393 S1Design
- Electronics for dosage sensing18 Sep 2025US 2025/0288748 A1
- Anti-cd3 antibodies, anti-cd123 antibodies and bispecific antibodies specifically binding to cd3 and/or cd12323 Sep 2021US 2021/0292423 A1
- Antibody formulations22 Aug 2019US 2019/0255173 A1
- Compositions and methods for analyzing histidine phosphorylation1 Jan 2015US 2015/0004173 A1
Most cited
By later US patents
- Derivatives of piperidinedione for protecting the myocardium presenting an anti-arrythmic activity, and pharmaceutical compositions26US 4,721,710 A1988
- Pyridazine derivatives active on the central nervous system, and medicaments in which they are present25US 4,721,711 A1988
- Pair of electrode pads15US D918,393 S12021 · Design
- Thiadiazoles and their use as antipicornaviral agents8US 5,650,419 A1997
- Reduced peptides which inhibit gastric secretion, process for their preparation and pharmaceutical compositions in which they are present3US 4,687,760 A1987